Actemra 400 MG per 20 ML Injection
- RxCUI
- 1657982
- RxNorm name
- Actemra 400 MG per 20 ML Injection
- Display name
- Actemra 400 MG per 20 ML Injection
- Full name
- Actemra 400 MG per 20 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACTEMRA | TOCILIZUMAB | Genentech, Inc. | 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 1657982 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13 | Actemra 400 MG in 20 ML Injection [PSN] · 20 ML tocilizumab 20 MG/ML Injection [Actemra] [SBD] · Actemra 400 MG per 20 ML Injection [SY] | 3 | 53 | These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA ® (tocilizumab) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2010 | 20251216 |